These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14530167)

  • 1. Repopulation in radiation oncology: perspectives of clinical research.
    Bentzen SM
    Int J Radiat Biol; 2003 Jul; 79(7):581-5. PubMed ID: 14530167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.
    Bernier J; Bentzen SM
    Eur J Cancer; 2003 Mar; 39(5):560-71. PubMed ID: 12628834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered fractionation in the treatment of head and neck cancer.
    Hu KS; Harrison LB
    Curr Oncol Rep; 1999; 1(2):110-23. PubMed ID: 11122807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation.
    Trott KR
    Acta Oncol; 1999; 38(2):153-7. PubMed ID: 10227435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered fractionation for head and neck cancer.
    Garden AS
    Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture.
    Tarnawski R; Widel M; Skladowski K
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1074-81. PubMed ID: 12605987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
    Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
    Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.
    Mendenhall WM; Parsons JT
    Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas.
    Marcu L; van Doorn T; Olver I
    Phys Med Biol; 2004 Aug; 49(16):3767-79. PubMed ID: 15446804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
    Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The time factor in oncological therapy].
    Baumann M; Herrmann T
    Strahlenther Onkol; 2000 Oct; 176(10):441-2. PubMed ID: 11068586
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
    Rosenthal DI; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for head and neck cancer: latest developments and future perspectives.
    Bernier J; Bentzen SM
    Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
    Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
    Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
    Bentzen SM; Bernier J
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
    Dobrowsky W; Dobrowsky E; Wilson GD
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):576-82. PubMed ID: 12573744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered-fractionated radiotherapy in locally advanced head and neck cancer.
    Bernier J; Horiot JC
    Curr Opin Oncol; 2012 May; 24(3):223-8. PubMed ID: 22123237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.